April 23, 2014 2:30 PM ET

Life Sciences Tools and Services

Company Overview of Fluorous Technologies, Inc.

Executive Profile

Thomas E. D'Ambra Ph.D.

Co-Founder and Non-Executive Chairman, Albany Molecular Research Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
57$4,090,123
As of Fiscal Year 2012

Background

Dr. Thomas E. D'Ambra, also known as Tom, Ph.D. co-founded Albany Molecular Research Inc. in 1991 and served as its Chief Executive Officer from 1991 to December 31, 2013. Dr. D'Ambra served as the President at Albany Molecular Research Inc. since February 2003. He served as the President of Molecular Research Inc., from 1991 to 1998. He co founded Coromed Inc., and served as its Vice President of Chemistry from 1989 to 1991. He served as Group Leader and Senior Research ...

Corporate Headquarters

815 Copeland Way
Pittsburgh, Pennsylvania 15232

United States

Phone: 267-225-5384
Fax: 412-826-3053

Board Members Memberships

Director
1991-Present
Co-Founder and Non-Executive Chairman

Education

BA
College of the Holy Cross
PhD
Massachusetts Institute of Technology

Other Affiliations

Annual Compensation

Salary$414,615
Total Annual Compensation$414,615

Stocks Options

Restricted Stock Awards$78,131
All Other Compensation$3,180,407
Unexercisable Options$140,000
Unexercisable Options Value$189,800
Total Value of Options$189,800
Total Number of Options$140,000

Total Compensation

Total Annual Cash Compensation$3,896,792
Total Short Term Compensation$414,615
Other Long Term Compensation$3,258,538
Total Calculated Compensation$4,090,123
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James C. Mullen Chief Executive Officer and Director
Patheon Inc.
$1.5M
Richard Ridinger Chief Executive Officer
Lonza Group AG
--
Kallam Satish Reddy B.Tech., M.S.Managing Director, Vice-Chairman, Member of The Management Council, Executive Director, Member of Management Committee, Member of Shareholders' Grievance Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
$3.6M
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Justin Korteasa Interim Managing Director
GlaxoSmithKline Consumer Nigeria Plc
--
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Fluorous Technologies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.